ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1000

$1.04M Total Retail Price of All Prescriptions

Rank: 41 out of 1000

826 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 826 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

47% of this provider’s 826 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 16,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,463 551 S3 1 1
METOPROLOL TARTRATE 1,480 914 2 19
SIMVASTATIN 1,420 834 3 3
OMEPRAZOLE 1,244 708 4 2
AMLODIPINE BESYLATE 1,082 656 5 6
CLONIDINE HCL 885 358 10 6 27
FUROSEMIDE 849 520 7 7
METFORMIN HCL 825 415 8 8
MELOXICAM 744 273 9 14
LISINOPRIL 728 373 10 5
HYDROCHLOROTHIAZIDE 524 268 11 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 401 198 12 20
POTASSIUM CHLORIDE 396 279 13 10
HYDRALAZINE HCL 391 256 14 74
ENALAPRIL MALEATE 316 162 15 58
RANITIDINE HCL 307 149 16 37
CARVEDILOL 290 141 17 15
GLIPIZIDE 289 148 18 62
CLOPIDOGREL 280 168 19 35
CYCLOBENZAPRINE HCL 275 28 R 20 39
GABAPENTIN 273 157 21 11
KLOR-CON M20 262 98 22 66
COLCRYS 259 134 23 171
LOSARTAN POTASSIUM 250 123 24 25
LEVOTHYROXINE SODIUM 248 151 25 4
LANTUS 241 131 26 68
INSULIN SYRINGE 241 127 26 93
WARFARIN SODIUM 233 149 28 22
PLAVIX 208 134 29 49
GLIMEPIRIDE 199 128 30 34
TAMSULOSIN HCL 193 120 31 33
ATENOLOL 182 119 32 24
QUETIAPINE FUMARATE 181 152 33 75
MEGESTROL ACETATE 180 161 R 34 134
DIGOXIN 172 84 35 52
SPIRONOLACTONE 171 122 36 78
DIOVAN 169 108 37 67
DONEPEZIL HCL 160 155 38 32
GLYBURIDE-METFORMIN HCL 159 84 R 39 121
NEXIUM 158 59 40 23
PREDNISONE 150 113 41 42
AMLODIPINE BESYLATE-BENAZEPRIL 149 73 42 59
CRESTOR 148 85 43 30
TRAMADOL HCL 140 83 44 13
POLYETHYLENE GLYCOL 3350 138 99 45 69
DICLOFENAC SODIUM 136 78 46 123
RISPERIDONE 133 126 47 87
ISOSORBIDE MONONITRATE ER 132 107 48 71
TRAZODONE HCL 131 37 49 29
VERAPAMIL ER 129 89 50 86
ZOLPIDEM TARTRATE 127 44 51 16
PAROXETINE HCL 126 81 52 63
THEOPHYLLINE ANHYDROUS 119 96 53 186
NAPROXEN 119 47 53 81
PANTOPRAZOLE SODIUM 118 98 55 28
TIZANIDINE HCL 114 18 56 76
PHENYTOIN SODIUM EXTENDED 110 56 57 115
NOVOLIN 70-30 110 41 57 160
FLUTICASONE PROPIONATE 106 49 59 40
SEROQUEL 101 81 60 157
METOPROLOL SUCCINATE 99 77 61 21
FAMOTIDINE 98 59 62 88
METHOCARBAMOL 96 34 R 63 79
LOSARTAN-HYDROCHLOROTHIAZIDE 95 54 64 38
SINGULAIR 94 49 65 84
HUMULIN 70-30 94 37 65 131
AZITHROMYCIN 92 31 67 36
SUCRALFATE 92 70 67 144
FLUCONAZOLE 90 12 69 102
LYRICA 90 0 69 47
ACTOS 86 63 71 119
METOCLOPRAMIDE HCL 84 60 72 99
DIVALPROEX SODIUM 82 81 73 113
ACETAMINOPHEN-CODEINE 82 68 S3 73 127
QUINAPRIL HCL 80 63 75 117
SANTYL 80 80 75 249
SERTRALINE HCL 78 37 77 26
BENZTROPINE MESYLATE 77 38 R 78 180
CITALOPRAM HBR 76 52 79 17
ADVAIR DISKUS 75 31 80 65
TRIAMCINOLONE ACETONIDE 74 40 81 159
PRAVASTATIN SODIUM 74 40 81 12
CIPROFLOXACIN HCL 73 44 83 46
KETOCONAZOLE 73 23 83 219
PHENYTOIN 71 44 85 257
ALBUTEROL SULFATE 71 66 85 142
ALLOPURINOL 70 30 87 31
CLOTRIMAZOLE-BETAMETHASONE 68 32 88 173
GEMFIBROZIL 67 15 89 105
ATORVASTATIN CALCIUM 67 32 89 18
MIRTAZAPINE 67 55 89 56
OXYBUTYNIN CHLORIDE ER 67 52 89 157
TERBINAFINE HCL 66 24 93 349
HYDROXYZINE HCL 66 51 R 93 153
LEVETIRACETAM 65 23 95 128
HALOPERIDOL 64 41 96 211
NAMENDA 63 61 97 43
LACTULOSE 62 61 98 162
NIFEDIPINE ER 62 44 98 130
NISOLDIPINE 61 14 100 373
NITROGLYCERIN PATCH 61 55 100 226
CYMBALTA 60 16 102 53
MECLIZINE HCL 59 45 103 80
CARBIDOPA-LEVODOPA 59 50 103 116
PROPRANOLOL HCL 58 43 105 135
ISOSORBIDE DINITRATE 57 42 106 224
NIFEDICAL XL 56 45 107 232
VENTOLIN HFA 56 16 107 83
PROAIR HFA 56 21 107 50
BYSTOLIC 55 21 110 126
CYPROHEPTADINE HCL 54 12 R 111 297
OXCARBAZEPINE 54 50 111 310
FLUOXETINE HCL 54 54 111 51
HUMULIN R 53 38 114 215
AMANTADINE 52 51 115 439
BUSPIRONE HCL 52 31 115 110
HYDROXYCHLOROQUINE SULFATE 52 26 115 316
AMITRIPTYLINE HCL 52 19 R 115 45
LOVASTATIN 52 29 115 41
BACLOFEN 51 29 120 129
METOLAZONE 51 12 120 167
ESCITALOPRAM OXALATE 51 30 120 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.